Vivo Ventures VI LLC 13D/13G Filings for

Vivo Ventures VI LLC 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-12
4:30 pm
Purchase		2020-12-3113GKalVista Pharmaceuticals, Inc.
KALV		Vivo Ventures VI LLC1,383,179
5.900%		1,383,179increase
(New Position)		Filing